Elective procedures for prostate cancer in the time of Covid-19: a multidisciplinary team experience
Alessandro Sciarra(Policlinico Umberto I), Valeria Panebianco(Sapienza University of Rome), Antonio Ciardi(Sapienza University of Rome), Daniela Musio(Sapienza University of Rome), Gian Maria Busetto(Sapienza University of Rome), Martina Maggi(Policlinico Umberto I), Stefano Salciccia(Policlinico Umberto I), Carlo Catalano(Unknown), Enrico Cortesi(Sapienza University of Rome), Francesco Del Giudice(Sapienza University of Rome)
Cited by 21
Related Papers
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
|The Lancet Oncology|2012|5.5k
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
|New England Journal of Medicine|2014|1.1k
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|618
Male Oxidative Stress Infertility (MOSI): Proposed Terminology and Clinical Practice Guidelines for Management of Idiopathic Male Infertility
|The World Journal of Men s Health|2019|468